tirzepatide surmount trials for the treatment of obstructive sleep apnea: Rationale, design, and sample baseline characteristics of the -OSA phase 3 trial ESC 2025: post-hoc SURMOUNT-5 data
Pay in 4 interest-free payments of $7.22 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27

























